alantolactone has been researched along with Osteogenic Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Han, J; Weng, Q; Zhang, Y | 1 |
1 other study(ies) available for alantolactone and Osteogenic Sarcoma
| Article | Year |
|---|---|
Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lactones; Neoplasm Invasiveness; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sesquiterpenes, Eudesmane; Signal Transduction | 2020 |